Received Jan 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | JF7DM | IM / LL |
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2LY39 | IM / RL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | MB599 | IM / RL |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 6 | Y1A212M | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y020586 | SC / LL |
During Varicella administration, dimpling of the skin was seen and at 5-10 post injection, redness/raised area around quarter sized appeared. Concerned vaccine was administered intradermally instead of subcutaneous. Ice was applied, minor decreased noted before patient left clinic. ER precautions reviewed. No pain, no itching, no s/s of allergic reaction.
None
None
None
None